• Article

Valdecoxib produces significantly fewer hospitalizations and is cost neutral compared with diclofenac for patients with rheumatoid arthritis in the UK healthcare setting

Bibliography

Von Scheele, B. (2004). Valdecoxib produces significantly fewer hospitalizations and is cost neutral compared with diclofenac for patients with rheumatoid arthritis in the UK healthcare setting. Annals of the Rheumatic Diseases, 63, 518-518.